Cited by 223DNA and Nucleic Acid ChemistryAdvanced biosensing and bioanalysis techniquesTelomeres, Telomerase, and Senescence

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Elevated Levels of G-Quadruplex Formation in Human Stomach and Liver Cancer Tissues

Open access

Abstract

Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells. Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-derived tissues using immunohistochemistry. We observe a significantly elevated number of G-quadruplex-positive nuclei in human cancers of the liver and stomach as compared to background non-neoplastic tissue. Our results suggest that G-quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation may be a characteristic of some cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0102711

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Validation of G-quadruplex nuclear staining by immunohistochemistry. A. Human MDA-MB-231 breast adenocarcinoma cell pellets were fixed, paraffin embedded and processed for IHC using the G-quadruplex-specific antibody BG4. No staining is observed in the absence of epitope retrieval. Scale bar corresponds to 20 µm. Nuclei are counterstained with haematoxylin (blue). B. Strong BG4 staining (brown) is readily apparent in cell nuclei following antigen retrieval with citrate-based buffer pH 6.0. C. No staining is observed in the absence of the BG4 primary antibody. D. No staining is seen following DNase treatment prior to BG4 staining. These results show that BG4 can be employed for DNA G-quadruplex detection by IHC staining.
Figure 1 Validation of G-quadruplex nuclear staining by immunohistochemistry. A. Human MDA-MB-231 breast adenocarcinoma cell pellets were fixed, paraffin embedded and processed for IHC using the G-quadruplex-specific antibody BG4. No staining is observed in the absence of epitope retrieval. Scale bar corresponds to 20 µm. Nuclei are counterstained with haematoxylin (blue). B. Strong BG4 staining (brown) is readily apparent in cell nuclei following antigen retrieval with citrate-based buffer pH 6.0. C. No staining is observed in the absence of the BG4 primary antibody. D. No staining is seen following DNase treatment prior to BG4 staining. These results show that BG4 can be employed for DNA G-quadruplex detection by IHC staining.CC BY · PubMed Central
Figure 2 Increased incidence of DNA G-quadruplex structures in human liver cancer relative to matched non-neoplastic tissue. Background non-neoplastic and cancer liver tissues were stained by IHC using the G-quadruplex-specific antibody BG4. A. The nuclei of non-neoplastic liver tissue from a hepatocellular carcinoma patient are mostly BG4-negative, with haematoxylin counterstaining (blue) evident. Scale bar corresponds to 50 µm. Note that the cytoplasmic granules are variable and likely to be heme-based artifacts sometimes observed in liver IHC. B. Neoplastic tissue from the same patient in A shows the extensive presence of BG4-positive nuclei (brown). C. The nuclei of non-neoplastic liver tissue for an intrahepatic cholangiocarcinoma patient are mostly BG4-negative. D. Neoplastic tissue from the same patient in C shows many BG4-positive nuclei. E. The nuclei of non-neoplastic liver tissue from a metastatic large cell undifferentiated lung carcinoma patient are mostly BG4-negative. F. Metastatic liver tissue isolated from the same patient in E shows many BG4-positive nuclei. G. Quantification of the number of BG4-positive nuclei in liver cancer and corresponding matched non-neoplastic tissues from nine patients. Error bars represent the standard error of the mean (s.e.m.) calculated when duplicate TMA cores were available. Overall, these results indicate that there are a greater number of G-quadruplex structures in liver cancer compared to background non-neoplastic tissue from the same individual.
Figure 2 Increased incidence of DNA G-quadruplex structures in human liver cancer relative to matched non-neoplastic tissue. Background non-neoplastic and cancer liver tissues were stained by IHC using the G-quadruplex-specific antibody BG4. A. The nuclei of non-neoplastic liver tissue from a hepatocellular carcinoma patient are mostly BG4-negative, with haematoxylin counterstaining (blue) evident. Scale bar corresponds to 50 µm. Note that the cytoplasmic granules are variable and likely to be heme-based artifacts sometimes observed in liver IHC. B. Neoplastic tissue from the same patient in A shows the extensive presence of BG4-positive nuclei (brown). C. The nuclei of non-neoplastic liver tissue for an intrahepatic cholangiocarcinoma patient are mostly BG4-negative. D. Neoplastic tissue from the same patient in C shows many BG4-positive nuclei. E. The nuclei of non-neoplastic liver tissue from a metastatic large cell undifferentiated lung carcinoma patient are mostly BG4-negative. F. Metastatic liver tissue isolated from the same patient in E shows many BG4-positive nuclei. G. Quantification of the number of BG4-positive nuclei in liver cancer and corresponding matched non-neoplastic tissues from nine patients. Error bars represent the standard error of the mean (s.e.m.) calculated when duplicate TMA cores were available. Overall, these results indicate that there are a greater number of G-quadruplex structures in liver cancer compared to background non-neoplastic tissue from the same individual.CC BY · PubMed Central
Figure 3 Increased incidence of G-quadruplex-positive cell nuclei across human liver cancers. A. Quantification of the number of BG4-positive nuclei in individual liver tissues including unmatched TMA cores. Non-neoplastic liver shows less BG4-positive nuclei compared to hepatocellular carcinoma or intrahepatic cholangiocarcinoma. Each column corresponds to a single tissue sample and error bars represent the s.e.m. calculated when duplicate tissue samples were available. B. Overall quantification of the number of BG4-positive nuclei in all non-neoplastic and cancer liver tissues. Error bars represent the s.e.m. **P<0.001, n = 19 and 32 for non-neoplastic and cancer cores, respectively. These results confirm the generality of more extensive G-quadruplex formation in the liver cancers compared to non-neoplastic tissues.
Figure 3 Increased incidence of G-quadruplex-positive cell nuclei across human liver cancers. A. Quantification of the number of BG4-positive nuclei in individual liver tissues including unmatched TMA cores. Non-neoplastic liver shows less BG4-positive nuclei compared to hepatocellular carcinoma or intrahepatic cholangiocarcinoma. Each column corresponds to a single tissue sample and error bars represent the s.e.m. calculated when duplicate tissue samples were available. B. Overall quantification of the number of BG4-positive nuclei in all non-neoplastic and cancer liver tissues. Error bars represent the s.e.m. **P<0.001, n = 19 and 32 for non-neoplastic and cancer cores, respectively. These results confirm the generality of more extensive G-quadruplex formation in the liver cancers compared to non-neoplastic tissues.CC BY · PubMed Central
Figure 4 Increased incidence of DNA G-quadruplex structures in human stomach cancer relative to matched non-neoplastic tissue. Gastric adenocarcinoma and signet ring cell carcinoma and matched background non-neoplastic tissues taken from the same patient were stained with the G-quadruplex-specific antibody BG4 by IHC. A. The nuclei of non-neoplastic stomach tissue from a gastric adenocarcinoma patient are mostly BG4-negative, with haematoxylin counterstaining (blue) readily apparent. Scale bar corresponds to 50 µm. B. Adenocarcinoma tissue from the same patient in A shows extensive numbers of BG4-positive nuclei (brown). C. The nuclei of non-neoplastic stomach tissue from a signet ring cell carcinoma patient are mostly BG4-negative. D. Signet ring cell carcinoma tissue from the same patient in C shows many BG4-positive nuclei. E. Quantification of the number of BG4-positive nuclei in the matched stomach cancers and background non-neoplastic tissues from two different patients. Error bars represent the s.e.m. calculated when duplicate TMA cores were available. These results indicate that there are more G-quadruplex structures in the nuclei of stomach cancer tissue than in non-neoplastic tissue from the same individual.
Figure 4 Increased incidence of DNA G-quadruplex structures in human stomach cancer relative to matched non-neoplastic tissue. Gastric adenocarcinoma and signet ring cell carcinoma and matched background non-neoplastic tissues taken from the same patient were stained with the G-quadruplex-specific antibody BG4 by IHC. A. The nuclei of non-neoplastic stomach tissue from a gastric adenocarcinoma patient are mostly BG4-negative, with haematoxylin counterstaining (blue) readily apparent. Scale bar corresponds to 50 µm. B. Adenocarcinoma tissue from the same patient in A shows extensive numbers of BG4-positive nuclei (brown). C. The nuclei of non-neoplastic stomach tissue from a signet ring cell carcinoma patient are mostly BG4-negative. D. Signet ring cell carcinoma tissue from the same patient in C shows many BG4-positive nuclei. E. Quantification of the number of BG4-positive nuclei in the matched stomach cancers and background non-neoplastic tissues from two different patients. Error bars represent the s.e.m. calculated when duplicate TMA cores were available. These results indicate that there are more G-quadruplex structures in the nuclei of stomach cancer tissue than in non-neoplastic tissue from the same individual.CC BY · PubMed Central
Figure 5 Increased incidence of G-quadruplex-positive cell nuclei across human stomach cancers. Confirmation of the increased presence of BG4-positive nuclei in a range of stomach cancer tissues compared to background non-neoplastic tissues including unmatched cases. A. The nuclei of non-neoplastic stomach tissues are largely BG4-negative. Cell nuclei were counterstained with haematoxylin (blue). Scale bar corresponds to 50 µm. B. Gastric adenocarcinoma tissue shows the extensive presence of BG4-positive nuclei (brown). C. Signet ring cell carcinoma shows many BG4-positive nuclei. D. Gastrointestinal stromal tumors (GIST) are largely BG4-positive (for the survey of stomach cancer only unmatched GIST tissues were available). E. Quantification of the number of BG4-positive nuclei in individual stomach tissues including unmatched TMA cores. Non-neoplastic stomach tissue shows less BG4-positive nuclei compared to adenocarcinoma, signet ring carcinoma or GIST. Each column corresponds to a single tissue sample and error bars represent the s.e.m. calculated when duplicate tissue samples were available. F. Overall quantification of the number of BG4-positive nuclei in all non-neoplastic and stomach liver tissues. Error bars represent the s.e.m. **P<0.001, n = 10 and 34 for non-neoplastic and cancer cores, respectively. These results confirm the generality of more extensive G-quadruplex formation in the stomach cancers compared t­o non-neoplastic tissues.
Figure 5 Increased incidence of G-quadruplex-positive cell nuclei across human stomach cancers. Confirmation of the increased presence of BG4-positive nuclei in a range of stomach cancer tissues compared to background non-neoplastic tissues including unmatched cases. A. The nuclei of non-neoplastic stomach tissues are largely BG4-negative. Cell nuclei were counterstained with haematoxylin (blue). Scale bar corresponds to 50 µm. B. Gastric adenocarcinoma tissue shows the extensive presence of BG4-positive nuclei (brown). C. Signet ring cell carcinoma shows many BG4-positive nuclei. D. Gastrointestinal stromal tumors (GIST) are largely BG4-positive (for the survey of stomach cancer only unmatched GIST tissues were available). E. Quantification of the number of BG4-positive nuclei in individual stomach tissues including unmatched TMA cores. Non-neoplastic stomach tissue shows less BG4-positive nuclei compared to adenocarcinoma, signet ring carcinoma or GIST. Each column corresponds to a single tissue sample and error bars represent the s.e.m. calculated when duplicate tissue samples were available. F. Overall quantification of the number of BG4-positive nuclei in all non-neoplastic and stomach liver tissues. Error bars represent the s.e.m. **P<0.001, n = 10 and 34 for non-neoplastic and cancer cores, respectively. These results confirm the generality of more extensive G-quadruplex formation in the stomach cancers compared t­o non-neoplastic tissues.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 223

Metadata

Authors
Biffi, G., Tannahill, D., Miller, J., Howat, W. J., & Balasubramanian, S.
Affiliations
University of Cambridge (GB)
Corresponding author
Balasubramanian, Shankar
Venue
PLoS ONE
Published
2014-07-17
Volume
9
Issue
7
Pages
e102711
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2100966371
Cited by
223
References
34
Citations by year
2026: 8 · 2025: 17 · 2024: 27 · 2023: 31 · 2022: 20 · 2021: 30 · 2020: 25 · 2019: 15 · 2018: 14 · 2017: 17 · 2016: 7 · 2015: 10 · 2014: 2
FWCI
4.92
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
Cancer Research UK (11961, A11961, 12488, 22310, C9681/A11961)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
G-quadruplex, G-quadruplex formation, immunohistochemistry, gastric cancer, liver cancer, tumor markers, DNA secondary structure, patient-derived tissue
MeSH terms
DNA, Gastric Mucosa, Humans, Immunohistochemistry, Liver, Liver Neoplasms, Stomach Neoplasms, Cell Line, Tumor, G-Quadruplexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review